InflaRx (IFRXN) Stock Forecast & Price Target
IFRXN Analyst Ratings
Strong Buy
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to InflaRx in the past 3 months
IFRXN Stock 12 Month Forecast
Average Price Target
MXN 125.97▲(259.92% Upside)Based on 4 Wall Street analysts offering 12 month price targets for InflaRx in the last 3 months. The average price target is MXN 125.97 with a high forecast of MXN 149.30 and a low forecast of MXN 93.31. The average price target represents a 259.92% change from the last price of MXN 35.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 149.30
AverageMXN 125.97
LowMXN 93.31
Highest Price TargetHighestMXN 149.30Average Price TargetMXN 125.97Lowest Price TargetLowestMXN 93.31
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Matthew Keller | H.C. Wainwright | MXN 149.30 | buy | 326.57%Upside | Reiterated | 10/23/26 | ||
| Joseph Stringer | Needham | MXN 149.30 | buy | 326.57%Upside | Initiated | 09/14/26 | ||
| Sam Slutsky | LifeSci Capital | MXN 93.31 | buy | 166.61%Upside | Reiterated | 08/06/26 | ||
| Steven Seedhouse | Cantor Fitzgerald | MXN 74.65→MXN 111.98 | buy | 219.93%Upside | Reiterated | 08/06/26 | ||
| Mazahir Alimohamed | Oppenheimer | MXN 167.96 | buy | 379.90%Upside | Reiterated | 07/20/26 | ||
| Ryan Deschner | Raymond James | MXN 130.64→MXN 167.96 | buy | 379.90%Upside | Reiterated | 05/13/26 | ||
| Yatin Suneja | Guggenheim | MXN 261.28 | buy | 646.51%Upside | Reiterated | 05/08/26 | ||
| Joseph Schwartz | Leerink Partners | ― | hold | ― | Reiterated | 12/31/25 | ||
| Andreas Argyrides | Chardan Capital | MXN 55.99→MXN 130.64 | buy | 273.25%Upside | Reiterated | 11/11/25 | ||
| Dev Prasad | Lucid Capital | MXN 55.99→MXN 447.90 | buy | 1179.72%Upside | Reiterated | 11/10/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Matthew Keller | 10/23/26 | MXN 149.30 | buy | 326.57%Upside | Reiterated | H.C. Wainwright | ||
| Joseph Stringer | 09/14/26 | MXN 149.30 | buy | 326.57%Upside | Initiated | Needham | ||
| Sam Slutsky | 08/06/26 | MXN 93.31 | buy | 166.61%Upside | Reiterated | LifeSci Capital | ||
| Steven Seedhouse | 08/06/26 | MXN 74.65→MXN 111.98 | buy | 219.93%Upside | Reiterated | Cantor Fitzgerald | ||
| Mazahir Alimohamed | 07/20/26 | MXN 167.96 | buy | 379.90%Upside | Reiterated | Oppenheimer | ||
| Ryan Deschner | 05/13/26 | MXN 130.64→MXN 167.96 | buy | 379.90%Upside | Reiterated | Raymond James | ||
| Yatin Suneja | 05/08/26 | MXN 261.28 | buy | 646.51%Upside | Reiterated | Guggenheim | ||
| Joseph Schwartz | 12/31/25 | ― | hold | ― | Reiterated | Leerink Partners | ||
| Andreas Argyrides | 11/11/25 | MXN 55.99→MXN 130.64 | buy | 273.25%Upside | Reiterated | Chardan Capital | ||
| Dev Prasad | 11/10/25 | MXN 55.99→MXN 447.90 | buy | 1179.72%Upside | Reiterated | Lucid Capital |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering InflaRx
3 Months
Success Rate5/10 ratings generated profit
50%
Average Return
+22.65%
Copying Matthew Keller's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +22.65% per trade.
1 Year
Success Rate9/10 ratings generated profit
90%
Average Return
+42.52%
Copying Matthew Keller's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +42.52% per trade.
2 Years
Success Rate8/10 ratings generated profit
80%
Average Return
+39.33%
Copying Matthew Keller's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +39.33% per trade.
IFRXN Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 7 | 7 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 9 | 7 | 7 | 5 |
In the current month, IFRXN has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IFRXN average Analyst price target in the past 3 months is 125.97.
IFRXN Financial Forecast
HighMXN -0.63
ConsensusMXN -1.17
LowMXN -1.68
IFRXN Earnings Forecast
Next quarter’s earnings estimate for IFRXN is -MXN 1.17 with a range of -MXN 1.68 to -MXN 0.63. The previous quarter’s EPS was -MXN 1.89. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 0.00
ConsensusMXN 0.00
LowMXN 0.00
IFRXN Sales Forecast
Next quarter’s sales forecast for IFRXN is MXN 0 with a range of MXN 0 to MXN 0. The previous quarter’s sales results were MXN 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
IFRXN Stock Forecast FAQ
What is MX:IFRXN’s average 12-month price target, according to analysts?
Based on analyst ratings, InflaRx’s 12-month average price target is Mex$125.97.
What is MX:IFRXN’s upside potential, based on the analysts’ average price target?
InflaRx has 259.92% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is InflaRx a Buy, Sell or Hold?
InflaRx has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is InflaRx’s share price target?
The average share price target for InflaRx is Mex$125.97. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$149.30, and the lowest forecast is Mex$93.31. The average share price target represents a 259.92% increase from the current price of Mex$35.
What do analysts say about InflaRx?
InflaRx’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of InflaRx?
To buy shares of MX:IFRXN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
